Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Mettler-Toledo Presents Live Webinar on Ensuring USP Compliance

Published: Friday, November 29, 2013
Last Updated: Thursday, November 28, 2013
Bookmark and Share
Mr. Gregory Martin will explain the implications of the latest USP revisions for balance users.

Mettler-Toledo has announced an upcoming webinar entitled “Ensuring USP Compliance with Revised Chapters on Weighing" with special guest presenter Mr. Gregory Martin, President of Complectors Consulting LLC.

The United States Pharmacopeia (USP) revisions to General Chapters <41> Balances and <1251> Weighing on an Analytical Balance will become official on December 1, 2013.

This webinar will be hosted on Dec 3, 2013 at 08:00 PST, 11:00 EST, 16:00 GMT; 17:00 CET. Event registration is at: http://tinyurl.com/webinarusp.

In this free educational webinar, laboratory managers and professionals who are concerned with regulatory affairs, compliance and metrology will learn about the details of these latest changes, understand the impact on their weighing processes and gain advice on how to update their standard operating procedures (SOP's) to remain compliant.

General Chapter <41> now states that accurate weighing must be performed using a calibrated balance. Repeatability and accuracy requirements are clarified and updated, with new acceptance limits and permissible test weights.

General Chapter <1251> has undergone major revisions focusing on balance qualification and operation, including the importance of "minimum weight". A daily balance check, typical in the pharmaceutical industry, is not actually a requirement. Instead, the type and frequency of balance checks should be determined by the risk and process tolerance of the application. Performing the right tests at the right intervals will ensure quality results and can potentially save time and money by eliminating unnecessary testing!

General Chapter <1251> also introduces "gravimetric dosing", a weighing methodology for analytical standard and sample preparation. This method involves weighing of the sample and diluent, resulting in concentration units of mg/g.

During this webinar, Mr. Gregory Martin will explain the implications of the latest USP revisions for balance users. Weighing and compliance experts from Mettler-Toledo will advise on how standard operating procedures (SOP's) should be updated to ensure compliance.

This webinar provides a unique opportunity to obtain expert advice during a live question and answer session after the presentation, allowing verification that individual weighing processes are up-to-date in advance of the next audit.

The key learning objectives for webinar attendees are: to discover which tests have to be periodically performed on balances used for quantitative analysis and which acceptance criteria apply from 1st Dec, based on the USP revisions; to recognize that a daily balance check is not a requirement and get insight into the risk-based approach recommended by USP General Chapter <1251>; to learn how to assess and calculate the minimum weight of a balance; and to find out more about gravimetric sample preparation and how to implement this method.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pharma Tech Trends and Development Cost Solutions
METTLER TOLEDO’s new on-demand webinar, “Methods to Improve Chemical Process Development,” takes on the challenges of today’s pharmaceutical market.
Thursday, April 04, 2013
Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!